Increasingly, payers, providers and regulators are looking at new types of data and evidence when evaluating price and value - especially for innovative products.
Understanding how these stakeholders define value, which evidence data matters, and where your portfolio may face risk around the world is an essential element in any market access strategy to protect and expand commercial success. And while these issues are most critical at launch, keeping on top of pricing and market access trends around the world will ensure you stay a step ahead throughout your product's lifecycle.
IQVIA helps you navigate market access by reaching for the data, connections and insights that will build the right story for your product, starting while your drug is still in clinical development.
By identifying and capturing the right market and competitive insights, you can accelerate approvals, assess risk, establish appropriate pricing, and enhance speed to market for new and innovative products.
Patient Reported Outcomes (PROs) matter. Payers and regulators around the world are increasingly incorporating the patient experience when considering coverage and pricing. Providers value it as a way to understand the real impact of a treatment on improved outcomes and quality of care.
IQVIA can help you understand the patient experience with:
IQVIA PriceBOX uses machine learning to generate accurate, transparent price metrics in real-time.
Access 470,000 products and nearly 40,000 drug profiles to analyze successful launch strategies and be ready for what’s next.
Discover proven strategies and insights refined over more than 5,000 launches around the world.
Go beyond the numbers to analytics-driven insights using artificial intelligence, machine learning and healthcare expertise.
Maximize the value of your brand with personalized, precise, and efficient communications.
Access clearer, more compelling support to demonstrate the value of your product.
Connect with KOLs, accelerate payer acceptance, provider awareness and market access with evidence, expert opinions and analytics that demonstrate value.